The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMDMG.L Regulatory News (MDMG)

  • There is currently no data for MDMG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ANNOUNCEMENT TO SHAREHOLDERS

14 Apr 2020 08:00

RNS Number : 4621J
MD Medical Group Investments PLC
14 April 2020
 

Announcement TO SHAREHOLDERS

 

14 April 2020, Moscow - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), a leading Russian private healthcare provider, kindly requests its shareholders to refrain from attending in person the Annual General Meeting of shareholders to be held on 23 April 2020 at Lapino hospital, Lapino 111, Odinzovskiy district, Moscow Region, Russian Federation at 10.00 am Moscow time, and to use an electronic voting method instead, due to the high spread of the COVID-19 virus.

 

This announcement contains inside information.

 

For further information please contact:

Investors

Media

Dmitry Yakushkin

MD Medical Group Investments Plc

Tel: +7 495 331 4120d.yakushkin@mcclinics.ru

EMTom Blackwell: +7 919 102 9064

Sergii Pershyn: +1 929 855 8188

MDMG@em-comms.com

About MD Medical Group

MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 42 modern healthcare facilities, including 6 hospitals and 36 out-patient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, Volgograd, Tula, Kazan, Vladivostok, Krasnodar and Rostov on Don

The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.

 

Forward-Looking Statements:

 

This press release contains forward looking statements, which are based on the Company's current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company's ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.

No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOAFLFEFSSIVLII
Date   Source Headline
4th Oct 20218:00 amRNSMDMG OPENS A NEW ONCOLOGICAL CARE CENTRE
24th Sep 20214:41 pmRNSSecond Price Monitoring Extn
24th Sep 20214:35 pmRNSPrice Monitoring Extension
19th Aug 20214:40 pmRNSSecond Price Monitoring Extn
19th Aug 20214:35 pmRNSPrice Monitoring Extension
17th Aug 20219:00 amRNSEndovascular heart surgery on a newborn at MDMG
30th Jul 20214:36 pmRNSPrice Monitoring Extension
29th Jul 20218:00 amRNSMDMG REPORTS 51% GROWTH IN REVENUE IN H1 2021
1st Jul 20214:41 pmRNSSecond Price Monitoring Extn
1st Jul 20214:35 pmRNSPrice Monitoring Extension
28th Jun 20218:00 amRNSFIRST OPEN-HEART SURGERY IN MDMG LAPINO HOSPITAL
29th Apr 20218:00 amRNSMDMG POSTS 40% REVENUE GROWTH IN Q1 2021
23rd Apr 20218:00 amRNSRESULTS OF THE AGM OF SHAREHOLDERS
6th Apr 20214:41 pmRNSSecond Price Monitoring Extn
6th Apr 20214:36 pmRNSPrice Monitoring Extension
22nd Mar 20213:15 pmRNSPUBLICATION OF 2020 ANNUAL REPORT
22nd Mar 20217:30 amRNSMDMG ANNOUNCEMENT OF THE ANNUAL GENERAL MEETING
22nd Mar 20217:00 amRNSMDMG POSTS 30% EBITDA AND 56% NET PROFIT GROWTH
16th Mar 20217:00 amRNSMDMG TO ANNOUNCE FY 2020 IFRS FINANCIAL RESULTS
8th Feb 20217:00 amRNSMDMG POSTS 18% REVENUE GROWTH IN FY 2020
1st Feb 20217:00 amRNSMD MEDICAL GROUP ANNOUNCES THE LAUNCH OF LAPINO-4
29th Dec 20208:00 amRNSMDMG ANNOUNCES START OF CONSTRUCTION OF LAPINO-4
30th Nov 20204:41 pmRNSSecond Price Monitoring Extn
30th Nov 20204:36 pmRNSPrice Monitoring Extension
10th Nov 20205:15 pmRNSCORRECTION TO MDMG ANNOUNCEMENT
10th Nov 20201:00 pmRNSMD MEDICAL GROUP ANNOUNCEMENT
9th Nov 20208:00 amRNSMDMG ANNOUNCES START OF TRADING ON MOEX
9th Nov 20207:00 amRNSMDMG POSTS SUSTAINABLE RESULTS AND REVENUE GROWTH
5th Nov 20205:45 pmRNSMDMG ANNOUNCES LISTING ON THE MOSCOW EXCHANGE
2nd Nov 20207:10 amRNSMDMG SUBMITS APPLICATION TO MOSCOW EXCHANGE
17th Sep 202012:30 pmRNSMD MEDICAL GROUP OPENS NEW SURGERY CENTRE LAPINO-2
9th Sep 202010:00 amRNSINFORMATION ON DIVIDEND PAYMENT FOR H1 2020
7th Sep 20208:00 amRNSMDMG POSTS 2% REVENUE GROWTH, 6% EBITDA GROWTH
7th Sep 20207:30 amRNSMDMG TO ANNOUNCE H1 2020 IFRS RESULTS (CORRECTION)
4th Sep 20209:42 amRNSRESULTS OF THE EXTRAORDINARY GENERAL MEETING
1st Sep 202010:00 amRNSMDMG TO ANNOUNCE H1 2020 IFRS FINANCIAL RESULTS
12th Aug 20208:00 amRNSMDMG Announcement of Extraordinary General Meeting
31st Jul 20208:00 amRNSMDMG reports H1 2020 operational results
28th Jul 20204:41 pmRNSSecond Price Monitoring Extn
28th Jul 20204:35 pmRNSPrice Monitoring Extension
30th Apr 202012:07 pmRNSSecond Price Monitoring Extn
30th Apr 202012:02 pmRNSPrice Monitoring Extension
30th Apr 20208:00 amRNSMD Medical Group Increases Revenue by 7% in Q12020
24th Apr 20208:00 amRNSResults of the AGM of shareholders
14th Apr 20208:00 amRNSANNOUNCEMENT TO SHAREHOLDERS
26th Mar 20207:00 amRNSLAPINO STARTS TREATMENT OF PATIENTS WITH PNEUMONIA
23rd Mar 202010:10 amRNSPUBLICATION OF 2019 ANNUAL REPORT
23rd Mar 20207:15 amRNSMDMG ANNOUNCEMENT OF THE ANNUAL GENERAL MEETING
23rd Mar 20207:00 amRNSMDMG POSTS 10% EBITDA GROWTH IN FY 2019
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.